Verona Pharma Plc - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Verona Pharma Plc. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Verona Pharma Plc. The Group's principal activity is researching and developing drugs for the treatment of allergic rhinitis and other chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease as well as chronic inflammatory diseases. The Group's lead drug compound, RPL554, is a long acting inhibitor of both phosphodiesterase 3 and phosphodiesterase 4 enzymes, two enzymes known to be of importance in the development and progression of immunological respiratory diseases, particularly rhinitis (hay fever) and asthma.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report